NICE INSIGHT REPORT
Mammalian Cell Culture, Biologics:2024 Market Insight, CDMO Pricing and Competitor Benchmarking
published June 2024
- 2024 pricing data for benchmarking and informed decision-making
- Regional breakdown of pricing: Americas, Europe, APAC
- 201 pages of relevant market insights, research, and analysis
- 72 profiles of biologics CDMOs specializing in mammalian cell culture
- Analysis of bispecific antibody clinical trials
- Emerging trends and technologies shaping the future of the market
Key market insights for innovators, CDMOs and investors in the biologics industry.
Make better decisions with our pricing and benchmarking report
Discover the mammalian cell culture contract development and manufacturing market with our comprehensive study on top CDMOs and insights into manufacturing trends. Benchmark your business with our in-depth pricing studies, which use years of primary data, to see how to best position your business. Dive into the focus on production of antibodies and antibody-based therapeutics.
Essential mammalian cell culture analysis for CDMOs and innovators
Understand the unique complexities of developing mammalian-based biologics and the trends and technologies shaping the market from exclusive insights from PhD scientists, NMEs and respected voices in the biopharma industry.
published June 2024
Unlock the rapidly changing biologics landscape with our all-in-one report, featuring essential market research, data and analysis.The Mammalian Cell Culture, Biologics: 2024 Market Insight, CDMO Pricing and Benchmarking provides
72 CDMO profiles of biologics CDMOs specializing in antibodies and mammalian cell culture
Up-to-date pricing information for biologics manufacture and production costs broken down by global region
Scientific analysis of the clinical trials for bispecific antibodies, including format, sponsors, and indications
Unique benefits and complexities of mammalian cell cultures for biologics manufacturing
Market growth projections for the biologics market, with distinct therapeutic segments
Innovative technologies for manufacturing and supply chain management of biologics